Comments
Loading...

Helmerich & Payne Analyst Ratings

HPNYSE
Logo brought to you by Benzinga Data
$24.88
0.080.33%
Pre-Market: Mar 21, 6:15 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$60.00
Lowest Price Target1
$24.00
Consensus Price Target1
$41.69

Helmerich & Payne Analyst Ratings and Price Targets | NYSE:HP | Benzinga

Helmerich & Payne Inc has a consensus price target of $41.69 based on the ratings of 15 analysts. The high is $60 issued by Morgan Stanley on November 21, 2022. The low is $24 issued by Barclays on February 19, 2025. The 3 most-recent analyst ratings were released by Barclays, RBC Capital, and Evercore ISI Group on February 19, 2025, February 7, 2025, and January 15, 2025, respectively. With an average price target of $32.67 between Barclays, RBC Capital, and Evercore ISI Group, there's an implied 31.28% upside for Helmerich & Payne Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Oct 24
1
Nov 24
1
Jan
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
RBC Capital
Evercore ISI Group
Citigroup
Goldman Sachs

1calculated from analyst ratings

Analyst Ratings for Helmerich & Payne

Buy NowGet Alert
02/19/2025Buy Now-3.55%Barclays
David Anderson61%
$36 → $24MaintainsEqual-WeightGet Alert
02/07/2025Buy Now40.66%RBC Capital
Keith Mackey49%
$41 → $35MaintainsSector PerformGet Alert
01/15/2025Buy Now56.74%Evercore ISI Group
James West64%
$48 → $39DowngradeOutperform → In-LineGet Alert
01/10/2025Buy Now60.76%Citigroup
Scott Gruber63%
$33 → $40UpgradeNeutral → BuyGet Alert
11/21/2024Buy Now—Benchmark
Kurt Hallead37%
—Reiterates → HoldGet Alert
11/20/2024Buy Now44.68%Barclays
David Anderson61%
$39 → $36MaintainsEqual-WeightGet Alert
11/15/2024Buy Now64.77%RBC Capital
Keith Mackey49%
$44 → $41MaintainsSector PerformGet Alert
10/16/2024Buy Now56.74%Barclays
David Anderson61%
$42 → $39MaintainsEqual-WeightGet Alert
09/13/2024Buy Now32.62%Citigroup
Scott Gruber63%
$41 → $33MaintainsNeutralGet Alert
08/29/2024Buy Now36.64%Goldman Sachs
Neil Mehta69%
$38 → $34MaintainsSellGet Alert
08/05/2024Buy Now—Benchmark
Kurt Hallead37%
—Reiterates → HoldGet Alert
07/26/2024Buy Now100.94%RBC Capital
Keith Mackey49%
$48 → $50MaintainsSector PerformGet Alert
07/25/2024Buy Now—Benchmark
Kurt Hallead37%
—Reiterates → HoldGet Alert
07/15/2024Buy Now60.76%B of A Securities
Chase Mulvehill49%
$42.5 → $40MaintainsBuyGet Alert
07/15/2024Buy Now44.68%Piper Sandler
Ian Macpherson61%
$39 → $36MaintainsNeutralGet Alert
05/06/2024Buy Now56.74%Piper Sandler
Ian Macpherson61%
$44 → $39MaintainsNeutralGet Alert
04/26/2024Buy Now—Benchmark
Kurt Hallead37%
—Reiterates → HoldGet Alert
04/26/2024Buy Now100.94%Susquehanna
Charles Minervino59%
$52 → $50MaintainsPositiveGet Alert
04/25/2024Buy Now—Benchmark
Kurt Hallead37%
—Reiterates → HoldGet Alert
04/16/2024Buy Now68.79%Citigroup
Scott Gruber63%
$40 → $42MaintainsNeutralGet Alert
04/08/2024Buy Now108.98%Susquehanna
Charles Minervino59%
$50 → $52MaintainsPositiveGet Alert
04/01/2024Buy Now100.94%Susquehanna
Charles Minervino59%
$50 → $50MaintainsPositiveGet Alert
02/20/2024Buy Now76.83%Piper Sandler
Ian Macpherson61%
$41 → $44MaintainsNeutralGet Alert
02/13/2024Buy Now100.94%Susquehanna
Charles Minervino59%
→ $50ReiteratesPositive → PositiveGet Alert
01/31/2024Buy Now92.91%RBC Capital
Keith Mackey49%
$46 → $48MaintainsSector PerformGet Alert
01/16/2024Buy Now—Benchmark
Kurt Hallead37%
—DowngradeBuy → HoldGet Alert
01/12/2024Buy Now32.62%Goldman Sachs
Neil Mehta69%
$37 → $33MaintainsSellGet Alert
01/10/2024Buy Now60.76%Barclays
David Anderson61%
$44 → $40DowngradeOverweight → Equal-WeightGet Alert
01/08/2024Buy Now64.77%Piper Sandler
Ian Macpherson61%
$47 → $41DowngradeOverweight → NeutralGet Alert
01/02/2024Buy Now—Seaport Global
Tom Curran34%
—DowngradeBuy → NeutralGet Alert
12/06/2023Buy Now100.94%Susquehanna
Charles Minervino59%
$53 → $50MaintainsPositiveGet Alert
11/13/2023Buy Now88.89%Piper Sandler
Luke Lemoine52%
$51 → $47MaintainsOverweightGet Alert
10/17/2023Buy Now76.83%Morgan Stanley
Daniel Kutz38%
$42 → $44MaintainsUnderweightGet Alert
08/09/2023Buy Now48.7%Goldman Sachs
Neil Mehta69%
$33 → $37MaintainsSellGet Alert
08/01/2023Buy Now68.79%Morgan Stanley
Daniel Kutz38%
$42 → $42ReiteratesUnderweight → UnderweightGet Alert
07/31/2023Buy Now104.96%Piper Sandler
Luke Lemoine52%
$45 → $51MaintainsOverweightGet Alert
07/31/2023Buy Now68.79%Morgan Stanley
Daniel Kutz38%
$42 → $42ReiteratesUnderweight → UnderweightGet Alert
07/31/2023Buy Now100.94%Benchmark
Kurt Hallead37%
→ $50ReiteratesBuy → BuyGet Alert
07/27/2023Buy Now100.94%Benchmark
Kurt Hallead37%
→ $50ReiteratesBuy → BuyGet Alert
07/19/2023Buy Now—Benchmark
Kurt Hallead37%
—UpgradeHold → BuyGet Alert
07/18/2023Buy Now52.72%Citigroup
Scott Gruber63%
$33 → $38MaintainsNeutralGet Alert
07/17/2023Buy Now68.79%Morgan Stanley
Daniel Kutz38%
$45 → $42MaintainsUnderweightGet Alert
07/10/2023Buy Now80.85%RBC Capital
Keith Mackey49%
$53 → $45DowngradeOutperform → Sector PerformGet Alert
06/28/2023Buy Now60.76%Capital One
Douglas Becker39%
→ $40Initiates → Equal-WeightGet Alert
06/08/2023Buy Now76.83%Barclays
David Anderson61%
$52 → $44MaintainsOverweightGet Alert
06/02/2023Buy Now60.76%Susquehanna
Charles Minervino59%
$45 → $40MaintainsPositiveGet Alert
05/19/2023Buy Now32.62%Citigroup
Scott Gruber63%
$42 → $33MaintainsNeutralGet Alert
05/09/2023Buy Now108.98%Barclays
David Anderson61%
$65 → $52MaintainsOverweightGet Alert
05/01/2023Buy Now100.94%Piper Sandler
Luke Lemoine52%
$65 → $50MaintainsOverweightGet Alert
04/28/2023Buy Now113%RBC Capital
Keith Mackey49%
$63 → $53MaintainsOutperformGet Alert
04/18/2023Buy Now80.85%Morgan Stanley
Daniel Kutz38%
$60 → $45DowngradeEqual-Weight → UnderweightGet Alert
04/03/2023Buy Now121.04%Susquehanna
Charles Minervino59%
$72 → $55MaintainsPositiveGet Alert
03/28/2023Buy Now52.72%Goldman Sachs
Neil Mehta69%
$44 → $38MaintainsSellGet Alert
03/27/2023Buy Now52.72%Goldman Sachs
Neil Mehta69%
$44 → $38MaintainsSellGet Alert
03/14/2023Buy Now189.36%Susquehanna
Charles Minervino59%
→ $72Reiterates → PositiveGet Alert
02/22/2023Buy Now84.87%Citigroup
Scott Gruber63%
$50 → $46MaintainsNeutralGet Alert
02/01/2023Buy Now189.36%Susquehanna
Charles Minervino59%
$65 → $72MaintainsPositiveGet Alert
01/19/2023Buy Now—Benchmark
Kurt Hallead37%
—Initiates → HoldGet Alert
01/09/2023Buy Now—B of A Securities
Chase Mulvehill49%
—UpgradeNeutral → BuyGet Alert
12/21/2022Buy Now96.93%Citigroup
Scott Gruber63%
$49 → $47MaintainsNeutralGet Alert
11/21/2022Buy Now141.13%Morgan Stanley
Connor Lynagh57%
$55 → $60MaintainsEqual-WeightGet Alert
11/18/2022Buy Now161.23%Susquehanna
Charles Minervino59%
$62 → $65MaintainsPositiveGet Alert
11/18/2022Buy Now173.28%RBC Capital
Keith Mackey49%
$63 → $68MaintainsOutperformGet Alert
11/18/2022Buy Now161.23%Piper Sandler
Luke Lemoine52%
$61 → $65MaintainsOverweightGet Alert
09/26/2022Buy Now121.04%Morgan Stanley
Connor Lynagh57%
$48 → $55UpgradeUnderweight → Equal-WeightGet Alert
08/31/2022Buy Now88.89%Citigroup
Scott Gruber63%
$49 → $47MaintainsNeutralGet Alert
08/01/2022Buy Now92.91%Morgan Stanley
Connor Lynagh57%
$45 → $48MaintainsUnderweightGet Alert
08/01/2022Buy Now133.1%Barclays
David Anderson61%
$52 → $58MaintainsOverweightGet Alert
07/14/2022Buy Now—Barclays
David Anderson61%
—UpgradeEqual-Weight → OverweightGet Alert
07/13/2022Buy Now80.85%Morgan Stanley
Connor Lynagh57%
$50 → $45MaintainsUnderweightGet Alert
07/13/2022Buy Now52.72%Goldman Sachs
Neil Mehta69%
$45 → $38MaintainsSellGet Alert
07/06/2022Buy Now96.93%Citigroup
Scott Gruber63%
$44 → $49MaintainsNeutralGet Alert
06/08/2022Buy Now149.17%Susquehanna
Charles Minervino59%
$55 → $62MaintainsPositiveGet Alert
06/01/2022Buy Now113%Piper Sandler
Ian Macpherson61%
$49 → $53MaintainsNeutralGet Alert
05/02/2022Buy Now100.94%Morgan Stanley
Connor Lynagh57%
$40 → $50MaintainsUnderweightGet Alert
05/02/2022Buy Now108.98%Barclays
David Anderson61%
$33 → $52MaintainsEqual-WeightGet Alert
04/29/2022Buy Now149.17%RBC Capital
Keith Mackey49%
$56 → $62MaintainsOutperformGet Alert
04/14/2022Buy Now64.77%Goldman Sachs
Neil Mehta69%
$36.5 → $41MaintainsSellGet Alert
04/13/2022Buy Now76.83%Piper Sandler
Ian Macpherson61%
$32 → $44MaintainsNeutralGet Alert
04/12/2022Buy Now113%Benchmark
Douglas Becker39%
→ $53Initiates → BuyGet Alert
04/11/2022Buy Now60.76%Morgan Stanley
Connor Lynagh57%
$29 → $40MaintainsUnderweightGet Alert

FAQ

Q

What is the target price for Helmerich & Payne (HP) stock?

A

The latest price target for Helmerich & Payne (NYSE:HP) was reported by Barclays on February 19, 2025. The analyst firm set a price target for $24.00 expecting HP to fall to within 12 months (a possible -3.55% downside). 22 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Helmerich & Payne (HP)?

A

The latest analyst rating for Helmerich & Payne (NYSE:HP) was provided by Barclays, and Helmerich & Payne maintained their equal-weight rating.

Q

When was the last upgrade for Helmerich & Payne (HP)?

A

The last upgrade for Helmerich & Payne Inc happened on January 10, 2025 when Citigroup raised their price target to $40. Citigroup previously had a neutral for Helmerich & Payne Inc.

Q

When was the last downgrade for Helmerich & Payne (HP)?

A

The last downgrade for Helmerich & Payne Inc happened on January 15, 2025 when Evercore ISI Group changed their price target from $48 to $39 for Helmerich & Payne Inc.

Q

When is the next analyst rating going to be posted or updated for Helmerich & Payne (HP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helmerich & Payne, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helmerich & Payne was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.

Q

Is the Analyst Rating Helmerich & Payne (HP) correct?

A

While ratings are subjective and will change, the latest Helmerich & Payne (HP) rating was a maintained with a price target of $36.00 to $24.00. The current price Helmerich & Payne (HP) is trading at is $24.88, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch